Eleazar Enrique Montalvan-Sanchez

Eleazar Enrique Montalvan-Sanchez

Auto-generated profile, based on publicly available information

Eleazar Enrique Montalvan-Sanchez

Section of Digestive Diseases, Department of Medicine, Yale School of Medicine , New Haven, CT

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 December 2021 in JCO Global Oncology
Verified
Journal Article
Open access
DNDalton Argean Norwood
Dalton Argean Norwood
EMEleazar Enrique Montalvan-Sanchez
Eleazar Enrique Montalvan-Sanchez
JCJuan E. Corral
Juan E. Corral
DEDagoberto Estévez-Ordoñez
Dagoberto Estévez-Ordoñez
APAndrea A. Paredes
Andrea A. Paredes
RDRicardo L. Domínguez
Ricardo L. Domínguez
PURPOSE: Population-based cancer registries (PBCRs) are critical for national cancer control planning, yet few low- and middle-income countries (LMICs) have quality PBCRs. The Central America Four region represents the principal LMIC region in the Western hemisphere. We describe the establishment of a PBCR in rural Western Honduras with first estimates for the 2013-2017 period. METHODS: The Western Honduras PBCR was established through a collaboration of academic institutions and the Honduras Ministry of Health for collection of incident cancer data from public and private health services. Data were recorded using the Research Electronic Data Capture (REDCap) web-based platform with data monitoring and quality checks. Crude and age-standardized rates (ASRs) were calculated at the regional level, following WHO methodology. RESULTS: The web-based platform for data collection, available ancillary data services (eg, endoscopy), and technical support from international centers (United States and Colombia) were instrumental for quality control. Crude cancer incidence rates were 112.2, 69.8, and 154.6 per 100,000 habitants overall, males, and females, respectively (excluding nonmelanoma skin cancer). The adjusted ASRs were 84.2, 49.6, and 118.9 per 100,000 overall habitants, males, and females, respectively. The most common sites among men were stomach (ASR 26.0, 52.4%), colorectal (ASR 5.11, 10.15%), and prostate (ASR 2.7, 5.4%). The most common sites in women were cervix (ASR 34.2, 36.7%), breast (ASR 11.2, 12.3%), and stomach (ASR 10.8, 11.7%). CONCLUSION: The Copán-PBCR represents a successful model to develop cancer monitoring in rural LMICs. Innovations included the use of the REDCap platform and leverage of Health Ministry resources. This provides the first PBCR data for Honduras and the Central America Four and confirms that infection-driven cancers, such as gastric and cervical, should be priority targets for cancer control initiatives.

2 October 2024 in BMJ Open Gastroenterology
Verified
Journal Article
Open access
PDF file
LNLauren D. Nephew
Lauren D. Nephew
SRSusan M Rawl
Susan M Rawl
ACAllie Carter
Allie Carter
NGNicole Garcia
Nicole Garcia
PMPatrick O Monahan
Patrick O Monahan
NCNaga Chalasani
Naga Chalasani
Objective To investigate how individual social determinants of health (SDOH) and cumulative social disadvantage (CSD) affect survival and receipt of liver transplant (LT) in patients with hepatocellular carcinoma (HCC). Methods We enrolled 139 adult patients from two Indianapolis hospital systems between June 2019 and April 2022. Structured questionnaires collected SDOH and social risk factor data. We compared SDOH and CSD by race, gender and disease aetiology, assigning one point per adverse SDOH. Multivariable competing risk survival analysis assessed associations between SDOH, CSD, survival and LT receipt. Results Black patients experienced higher CSD than white patients in the cohort (5.4±2.5 vs 3.2±2.1, p<0.001). Black patients were significantly more likely to have household incomes <US$15 000 per year (52.6% vs 18.3%, p=0.003), to be insured by Medicaid (57.9% vs 33.0%, p=0.04), and to live in high Social Deprivation Index areas (68.4% vs 17.5%, p<0.001) than white patients. Patients with hepatitis C virus and alcohol-related liver disease had more adverse SDOH than those with metabolic dysfunction-associated steatotic liver disease, while there were no significant differences by gender. On multivariable analysis, a higher health literacy score was a significant predictor of survival (HR 2.54, 95% CI 1.19 to 5.43 CI, p=0.02) and higher CSD was associated with a lower probability of receipt of LT (HR 0.80, 95% CI 0.68 to 0.95, p=0.01). Conclusions There are significant racial and aetiology-related differences in SDOH burden. Low health literacy and high CSD are linked to worse outcomes in HCC patients. Health literacy screening and targeted interventions for those with high CSD could improve LT access and survival rates.

1 July 2024 in Cancer Epidemiology, Biomarkers & Prevention
Verified
Journal Article
Closed access
RDRicardo L. Dominguez
Ricardo L. Dominguez
EMEleazar E. Montalvan-Sanchez
Eleazar E. Montalvan-Sanchez
DNDalton A. Norwood
Dalton A. Norwood
ARAida Rodriguez-Murillo
Aida Rodriguez-Murillo
LDLucia Dominguez
Lucia Dominguez
DMDouglas Morgan
Douglas Morgan
Background: Two-thirds of global cancers occur in low/middle income countries (LMIC). Northern Central America is the largest LMIC region in the Western Hemisphere and lack cancer registries to guide cancer control. We conducted a gastric cancer survival study in rural Western Honduras, characterized as having among the highest gastric cancer incidence rates in Latin America. Methods: The cohort of incident gastric cancer diagnosed between 2002 and 2015 was studied with active follow-up with household visits. The regional gastric cancer registry was primary for case identification, with completeness examination with hospital data and national death certificates. Cox regression models were used for survival calculations. Results: Survival follow-up was achieved in 741/774 patients (95.7%). Household interviews were conducted in 74.1% (n = 549); 65.7% were male, median age at diagnosis was 64 years, 24.5% were <55 years; 43.9% of tumors had pyloric obstruction; 45.2%, 43.2%, and 7.3% of histology was intestinal, diffuse, and mixed, respectively. A total of 24.7% patients received treatment. The 5-year survival rates were 9.9% for both males and females, 7.7% for age <45, and 7.9% for diffuse gastric cancer. Median survival time was 4.8 months [95% confidence interval (CI), 4.2–5.6]. In the final Cox regression model including age, sex, Lauren subtype, and poverty index, only treatment was significantly associated with survival (hazard ratio = 2.43, 95% CI, 1.8–3.2). Conclusions: Markedly low gastric cancer 5-year survival rates are observed in rural Central America. The majority of patients present with advanced disease and a minority have access to therapy. Impact: The findings have implications for cancer control in the Central America LMICs and for US Latino populations. See related commentary by Riquelme and Abnet, p. 1550

1 August 2024 in Gut and Liver
Verified
Journal Article
Open access
PDF file
RBRenato Beas
Renato Beas
AGAmbar Godoy
Ambar Godoy
DNDalton A. Norwood
Dalton A. Norwood
YAYsaith Orellana Ascencio
Ysaith Orellana Ascencio
DIDiego Izquierdo-Veraza
Diego Izquierdo-Veraza
SKSatya Kurada
Satya Kurada
Renato Beas, Ambar Godoy, Dalton A. Norwood, Ysaith Orellana Ascencio, Diego Izquierdo-Veraza, Eleazar E. Montalvan-Sanchez, Mirian Ramirez, Satya Kurada. Gut and Liver -0001;0:. https://doi.org/10.5009/gnl240063

16 August 2024 in Cancer Prevention Research
Verified
Journal Article
Closed access
PDF file
EMEleazar E. Montalvan-Sanchez
Eleazar E. Montalvan-Sanchez
JHJessica Hernandez-Marrero
Jessica Hernandez-Marrero
DNDalton A. Norwood
Dalton A. Norwood
MGMaria Gonzalez-Pons
Maria Gonzalez-Pons
RDRicardo L. Dominguez
Ricardo L. Dominguez
DMDouglas Morgan
Douglas Morgan
Gastric adenocarcinoma (GAC) is the fourth leading global cause of cancer mortality and leading infection-associated cancer. High-incidence regions of GAC include Latin America and Eastern Asia. Immigrants from high-incidence regions maintain their GAC risk. GAC is a major U.S. cancer disparity, and its incidence rates are 2 to 10 times higher in non-White populations. Emerging guidelines recommend 3-year surveillance endoscopy for patients with high-risk gastric premalignant conditions (GPMC). Clinical trials of GPMC chemoprevention agents are lacking. We conducted a NCI Division of Cancer Prevention–funded, phase II placebo-controlled chemoprevention trial in patients with GPMCs (atrophic gastritis and intestinal metaplasia) with a highly bioavailable preparation of curcuminoids (Meriva). The trial sites in Puerto Rico and rural Honduras had important characteristics: (i) representative Caribbean and Mesoamerican populations, linked to large U.S. immigrant populations; (ii) high prevalence of Helicobacter pylori infection and GPMCs; (iii) the absence of turmeric and curcuminoids in local diets; and (iv) proven bidirectional collaboration with U.S. academic institutions. H. pylori–negative patients with GPMCs were randomized to the study drug (500 mg po bid) or placebo for 180 days (NCT02782949), with primary outcomes based upon histologic parameters. Principal study challenges included (i) an international regulatory environment; (ii) research infrastructure strengthening, particularly in Central America; (iii) participant recruitment in Honduras, wherein only 10% to 15% are H. pylori negative; (iv) the COVID-19 pandemic; and (v) natural disasters (three hurricanes). There were no losses to follow-up related to the pandemic or natural disasters. In conclusion, the south–south partnership provides a model for chemoprevention and translational studies in Latino populations with prevalent cancers, such as GAC.

1 June 2022 in Gastroenterology Research
Verified
Journal Article
Open access
PDF file
EMEleazar E. Montalvan-Sanchez
Eleazar E. Montalvan-Sanchez
RBRenato Beas
Renato Beas
DNDalton Argean Norwood
Dalton Argean Norwood
AAAhmad Mahmoud Alkashash
Ahmad Mahmoud Alkashash
AMAida A. Rodriguez Murillo
Aida A. Rodriguez Murillo
GCGerardo Calderon
Gerardo Calderon
We report a case of an 81-year-old male immigrant from a Latin American developing country with a high burden of upper gastrointestinal neoplasms, who presented with a small bowel gastrointestinal stromal tumor (GIST) after 2 years of delay in the diagnosis due to multiple barriers to healthcare. The patient presented with a partial intestinal obstruction in an abdominal computed tomography (CT) scan suggestive of a GIST. Surgical resection was performed, and adjuvant therapy was initiated with imatinib (a tyrosine kinase inhibitor) after the diagnosis was confirmed. The patient had a successful outcome. Due to his migratory status, the patient planned to follow up with different health providers in two different countries, which constitutes a common challenge in the immigrant population. Gastroenterol Res. 2022;15(3):142-147 doi: https://doi.org/10.14740/gr1514